ZAMPRELTA
Table of contents:
The "ZAMPRELTA" trademark, serial number 85732542 , was filed on 19th of September 2012 with a mark drawing code of 4000 and its transaction date is 85732542. Since 4th of February 2014, the document can be found in the L20 law office in the publication and issue section. The employee responsible is FERRAIUOLO, DOMINIC J and the date it was published for opposition on 12/10/2013. The status of the trademark was checked last on 02/04/2014.
The corresponded responsible for this trademark is MAURY M. TEPPER, III, located at TEPPER & EYSTER, PLLC, 3724 BENSON DR, RALEIGH, NC 27609-7321.The state or country where the trademark was organized is by Novartis Ag. The legal entity type behing it is a Corporation, located at Ch-4002, Basel, zip .
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 09/22/2012 |
| Primary Code | 005 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| GS0051 | (Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives(Based on 44(d) Priority Application) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives |
| FOREGIN REGISTRATION | |
| Foreign Filing Date | 09/19/2012 |
|---|---|
| Foreign Registration Date | 09/14/2012 |
| Foreign Expiration Date | 09/14/2022 |
| Foreign Application Number | 61039/2012 |
| Country | CH |
| Foreign Registration Number | 634332 |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 02/04/2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
| 12/10/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
| 12/10/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 11/20/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
| 11/06/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 11/04/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 11/01/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 11/01/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 11/01/2013 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | I - Incoming Correspondence | ERSI | |
| 07/01/2013 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS2 | |
| 07/01/2013 | INQUIRY TO SUSPENSION E-MAILED | S | GNSI - INQUIRY TO SUSPENSION E-MAILED | |
| 07/01/2013 | SUSPENSION INQUIRY WRITTEN | R - Renewal | CNSI - SUSPENSION INQUIRY - COMPLETED | |
| 07/01/2013 | LIE CHECKED SUSP - TO ATTY FOR ACTION | S | RCCK - LIE CHECKED SUSP - TO ATTY FOR ACTION | |
| 06/24/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 12/21/2012 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 12/21/2012 | LETTER OF SUSPENSION E-MAILED | F - First Action | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 12/21/2012 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 12/21/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 09/22/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 09/22/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "ZAMPRELTA" trademark, serial number 85732611 , was filed on 19th of September 2012 with a mark drawing code of 4000 and its transaction date is 85732611. Since 24th of September 2012, the document can be found in the law office in the publication and issue section. The status of the trademark was checked last on 09/24/2012.
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.